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Abstract: Background: While sepsis may have especially marked impacts in young adults, there is
limited population-based information on its epidemiology and trends. Methods: Population-based
longitudinal study on sepsis in adults aged 20–44 years using the 2006–2015 Spanish national hospital
discharge database. Cases are identified by an ICD-9-CM coding strategy. Primary endpoints are
incidence and in-hospital mortality. Trends are assessed for annual percentage change (AAPC) in
rates using Joinpoint regression models. Results: 28,351 cases are identified, representing 3.06% of
all-cause hospitalisations and a crude incidence of 16.4 cases/100,000 population aged 20–44. The
mean age is 36 years, 58% of cases are men, and around 60% have associated comorbidities. Seen
in one third of cases, the source of infection is respiratory. Single organ dysfunction is recorded in
45% of cases. In-hospital mortality is 24% and associated with age, comorbidity and extent of organ
dysfunction. Incidence rates increase over time in women (AAPC: 3.8% (95% CI: 2.1, 5.5)), whereas
case-fatality decline with an overall AAPC of −5.9% (95% CI −6.6, −5.2). Our results indicate that
sepsis is common in young adults and associated with high in-hospital mortality, though it shows a
decreasing trend. The substantial increase in incidence rates in women needs further research.
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1. Introduction
Adult sepsis, defined as the dysregulated host response to infection resulting in organ dysfunction,
is a major global health problem and represents a challenge for physicians and health care systems all
over the world due to its high incidence, mortality and economic impact [1–4]. Additionally, survivors
show a substantially worse quality of life, physical and cognitive decline and an increased risk of death
several years after an episode [3,5].
The negative impact of sepsis, including a shortened lifespan and increased burden of morbidity
and disability, can be especially significant in the case of young adults under 44 years of age as it is the
population-group in which the majority of individuals are at their maximum physiological, biological
and cognitive-intellectual capacity and supposes the active demographic, labor and economic force of
the society.
There is limited population-based information on the epidemiology and trends of sepsis in these
adults, however, especially in Europe where data from 2015 reveal that adults aged 20–44 years account
for 34% of the population [6]. The size of this population and the results of several studies indicating that
the incidence of sepsis has increased in the general population [4,7,8], make that information essential
to assess, considering the burden of the disease and to estimate healthcare resource requirements.
Thus, this population-based study was designed to address the epidemiological characteristics and
trends of sepsis in young adults in Spain.
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2. Materials and Methods
The data for this study were compiled from the Spanish Health Ministry’s National Minimum Basic
Data Set (MBDS). Regarding the Spanish National Health System, when a patient is discharged from
hospital, the responsible physician is required by law to record all diagnoses and clinical procedures
performed according to the ICD-9-CM system. This information is then subjected to a validation
process and consolidated in the MBDS. This database is considered to be representative of the national
population as it includes data on over 90% of all hospitalizations produced annually in the country [9].
Viewing this database, each hospitalization is treated as a single registry and includes information
on patient demographics, date of admission and whether elective or non-elective, date and destiny of
discharge along with diagnostic codes including the main diagnosis, 13 additional diagnoses, and up
to 20 procedures conducted during the patient’s hospital stay.
2.1. Case Identification
All hospitalizations of adults aged 20–44 years produced over a 10-year period from January 1, 2006
to December 31, 2015 were identified. To capture sepsis, we used an ICD-9-CM widely used strategy to
define infection and organ dysfunction. To define infection, the following codes were used [7,8,10]:
038.0 (streptococcal septicaemia), 038.1 (staphylococcal septicaemia), 038.2 (pneumococcal septicaemia),
038.3 (septicaemia due to anaerobes), 038.4 (septicaemia due to other Gram-negative organisms), 038.8
(other specified septicaemias), 038.9 (unspecified septicaemia), 003.1 (salmonella septicaemia); 020.2
(septicaemia plague); 036.2 (meningococcal septicaemia); 036.3 (Waterhouse–Friderichsen syndrome);
054.5 (herpetic septicaemia); 098.89 (gonococcemia); 112.5 (systemic candidiasis); 112.81 (candidal
endocarditis); 117.9 (other and unspecified mycoses) and 790.7 (bacteraemia). We also included the
ICD-9-CM codes 995.91 (sepsis, systemic inflammatory response syndrome due to infectious process
without organ dysfunction) and 995.92 (severe sepsis) [10].
To identify acute organ dysfunction, the ICD-9-CM codes detailed below were captured:
Respiratory: 518.81 (acute respiratory failure), 518.82 (other pulmonary insufficiency), 518.84
(acute-on-chronic respiratory failure), 518.85 (acute respiratory distress syndrome after shock or trauma),
786.09 (respiratory distress, insufficiency), 799.1 (respiratory arrest), and 96.7 (invasive mechanical
ventilation); Cardiovascular: 785.5 with all subcodes (shock without mention of trauma, includes
785.51, 785.52, 785.59); renal: 584 with all subcodes (acute renal failure), 580 (acute glomerulonephritis),
and 39.95 (hemodialysis); Hepatic: 570 (acute and subacute necrosis of liver), 572.2 (hepatic coma),
and 573.3 (hepatitis, unspecified); Haematologic: 286.6 (defibrination syndrome), 286.9 (other and
unspecified coagulation defects), and 287.3–5 (secondary thrombocytopenia, unspecified); Neurologic:
293 (acute delirium), 348.1 (anoxic brain damage), 348.3 (encephalopathy, unspecified), 357.82 (critical
illness polyneuropathy), 780.01 (coma), 780.09 (drowsiness, unconsciousness, stupor), and 89.14
(electroencephalogram); and Metabolic: 276.2 (acidosis metabolic or lactic).
Comorbidity was defined using the Charlson’s index adapted and validated by Deyo for the
ICD-9-CM [11]. This index includes specific comorbid conditions of known prognostic value and has
been shown effective to assess the mortality risk in patients with sepsis [12]. Further, due to the impact
of comorbidity on the outcome of sepsis [13], cases were stratified according to the presence or not of
comorbidities as defined by the Charlson’s index.
Concerning every case, the main diagnostic group at hospital admission was assessed according
to the ICD-9-CM chapters: infectious disease (001–139); neoplasms (140–239); endocrine diseases
(240–279); hematological diseases (280–289); neurological diseases (320–389); diseases of the circulatory
system (390–459); respiratory diseases (460–519); diseases of the digestive system (520–579); diseases of
the genitourinary tract (580–629); diseases of the skin and subcutaneous tissue (680–709); diseases of
the musculoskeletal system and connective tissue (713–739) and injury-poisoning (800–999).
Episodes were described as surgical when this was indicated by their GRD (diagnosis-related
group code). To identify specific microorganisms, code 041 was included as indicated by the ICD-9-CM
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coding manual for the purpose of identifying specific microorganisms in the case of diseases classified
under the heading ‘other’ [9]. Hospitalization costs were estimated from their respective GRDs.
As the data examined were sourced from anonymized records, there was no need for informed
consent [14].
2.2. Data Analysis and Presentation
During this descriptive study, the main variables examined were the incidence and mortality
of sepsis and their trends over the study period. Other variables examined were demographics,
comorbidities, microbiological data, number and type of organ dysfunction, and the use of hospital
resources (length of hospital stay and costs).
Categorical variables are provided as their absolute frequencies and percentages, and continuous
variables as means and standard deviations. Age groups were defined as 5-year intervals. In-hospital
case-fatality rate (CFR) was calculated as the number of deaths divided by the number of cases of
sepsis and expressed as a percentage. To identify factors associated with in-hospital mortality, an
exploratory logistic regression was performed including variables of clinical relevance such as sex, age
group and comorbidity burden, and others of known impact on the outcome of sepsis such as number
of organ dysfunctions. Results are presented as odds ratios (OR) and 95% confidence intervals (CI).
Crude incidence rates were calculated using national population data, of those aged 20–44
years, from the Spanish institute of statistics (INE) and results expressed per 100,000 population [15].
Age-adjusted rates were calculated by direct standardization referred to the European population [16].
To assess possible temporal changes in incidence and in-hospital CFR, we used Joinpoint regression
models [17]. These generalized linear models follow a Poisson distribution and served to estimate
annual average percentage change (AAPC) and its 95% CI for each trend [18].
All statistical tests were performed using the package Stata® version 15 (StataCorp LP, College
Station, Texas, USA) and Joinpoint regression programme version 4.7.0.0 (National Cancer Institute,
Bethesda, MD, USA). Significance was set at p < 0.05.
2.3. Data Availability
The data came from anonymized registries. According to the confidentiality agreement signed
with the Ministry of Health, Consumer Affairs and Social Welfare, the data from this study cannot be
shared with third parties. The authors did not have special access privileges. Should any researcher
wish to gain access to these data, they can do so by applying directly to the Ministry through
the following link: https://www.mscbs.gob.es/estadEstudios/estadisticas/estadisticas/estMinisterio/
SolicitudCMBDdocs/Formulario_Peticion_Datos_CMBD.pdf.
3. Results
Regarding 9,271,272 hospital discharge registries corresponding to adults aged between 20 and 44
years for the period 2006–2015 in Spain, 28,351 episodes of sepsis were identified, representing 3.06%
of all-cause hospitalizations in this age group.
The crude incidence rate for the cohort was 16.36 cases per 100,000 persons; being higher in men
(18.62 per 100,000 persons) than women (13.9 per 100,000 persons). Shown in Figure 1, incidence
increased with age in cases with and without comorbidities, but the increase was greater among those
with comorbidities. The increase with age was observed both in men and women, although in almost
every age group the incidence was higher among men.
The overall mean age was 36 years and 58% of cases were men. Roughly 41% of cases (38.2% in
men, 46% in women) had a Charlson score of 0. The most frequent comorbidities in the remaining
cases were liver disease, cancer and AIDS (Table 1). This table also shows the demographic and
clinical characteristics of the episodes stratified according to the presence or absence of comorbidities.
Regarding most cases, hospital admission was non-elective via the emergency services and, in one
third of cases, the cause of hospitalization was infection.
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potential source of infection in most cases was respiratory, followed by genitourinary and
procedure-related infections. Found i close t 6 % of case , at least one ic oorganism was identified.
Gram-n gati bact ria were slightly more frequent than other microorganisms. The presence of
bacteraemi was recorded in 21% (n = 5908) of the epis des, this rate being higher in those with
(24% versus 16.5%).
S en in arou d 45% of cases, single organ dy function was present, while 26% and 25% showed
the dysfunc ion of two or more orga s, respectiv ly. Shown n Table 1, the percentage f cases with
m re than two orga dysfu ctions was greater among th se with comorbidities. The most frequently
aff c ed organs wer the lungs, r corded in more than half of the cases, followed by the card ovascular
system and kidneys. Renal dysfunction was much more frequ nt in th subset with comorbidities.
Essentially, of the 3191 cases in which patients underwent dialysis, 2444 (77%) belonged to this subset.
The us of invasive mechanical ventilation was, nevertheless, more frequent in the group without
comorbidities and, overall, this measure was employed in 38% of cases.
The mean hospit l sta was 28.4 days and the mean cost per case was 17,878 Euros. There were
no significant differences betwe n the cases with or without comorbidities.
Six thousand, ight hundred and ight hospital deaths were recorded, which corresponds to an
overall case-fatality ra e CFR of 24%, but this rate varied according to various demographic and clinical
charact ristics. Thus, as s own in Table 2, it was higher in men than in wom n and clearly increased
wi a e.
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Age, mean ± SD 35.73 ± 6.63 34.59 ± 6.83 36.55 ± 6.37 <0.001
Age group, years <0.001
20–24 2381 (8.4) 1307 (11.1) 1074 (6.5)
25–29 3217 (11.4) 1619 (13.7) 1598 (9.7)
30–34 4971 (17.5) 2313 (19.6) 2658 (16.1)
35–39 7287 (25.7) 3054 (25.9) 4233 (25.6)
40–44 10,495 (37.0) 3505 (29.7) 6990 (42.4)
Sex <0.001
Men 16,501 (58.2) 6299 (53.4) 10,202 (61.6)
Women 11,848 (41.8) 5498 (46.6) 6350 (38.4)
Non-Elective Hospital Admission 24,988 (88.1) 10,916 (92.5) 14,072 (85.0) <0.001
Medical Admission 18,543 (65.5) 11,312 (68.4) 7231 (61.4) <0.001
Hospital Admission Main Diagnosis
(ICD-9-CM chapter)
Infectious disease 9164 (32.3) 3844 (32.6) 5320 (32.1) 0.432
Respiratory disease 3774 (13.3) 1874 (15.9) 1900 (11.5) <0.001
Trauma & poisoning 3640 (12.8) 2066 (17.5) 1574 (9.5) <0.001
Digestive disease 2938 (10.4) 1241 (10.5) 1697 (10.2) 0.467
Cancer 2137 (7.5) 94 (0.80) 2043 (12.3) <0.001
Genitourinary disease 1560 (5.5) 874 (7.4) 686 (4.1) <0.001
Circulatory disease 1372 (4.8) 186 (1.6) 1186 (7.2) <0.001
Charlson Score, mean ± SD 1.77 ± 2.29 NA 3.03 ± 2.27
Specific Comorbidities ‡
Liver disease 5670 (20.0) 5670 (34.2)
Cancer 4320 (15.2) 4320 (26.1)
AIDs 2298 (8.1) 2298 (13.9)
Chronic kidney disease 2327 (8.2) 2327 (14.1)
COPD 1714 (6.1) 1714 (10.4)
Cardiac insufficiency 1588 (5.6) 1588 (9.6)
Diabetes 1646 (5.8) 1646 (9.9)
Hemiplegia or Paraplegia 1213 (4.3) 1213 (7.3)
Stroke 1052 (3.7) 1052 (6.4)
Rheumatologic disease 475 (1.7) 475 (2.9)
Peripheral vascular event 373 (1.3) 373 (2.2)
Acute myocardial infarction 234 (0.8) 234 (1.4)
Infection Site ‡
Respiratory 8414 (29.7) 3808 (32.3) 4606 (27.8) <0.001
Genitourinary 4953 (17.5) 2439 (20.7) 2514 (15.2) <0.001
Procedure-related 4352 (15.4) 1830 (15.5) 2522 (15.2) 0.526
Abdominal 3271 (11.5) 1512 (12.8) 1759 (10.6) <0.001
Soft tissue 1265 (4.5) 549 (4.7) 716 (4.3) 0.188
Central nervous system 799 (2.8) 369 (3.1) 430 (2.6) 0.008
Cardiac 375 (1.3) 124 (1.1) 251 (1.5) 0.001
Other/Not specified 7112 (25.1) 2625 (22.3) 4487 (27.1) <0.001











Microbiological Data ‡ 16,225 (57.2) 6568 (55.7) 9657 (58.3) <0.001
Gram-positive bacteria 8340 (51.4) 3336 (50.8) 5004 (51.8)
Gram-negative bacteria 9457 (58.3) 3959 (60.3) 5498 (56.9)
Fungus 815 (5.0) 266 (4.1) 549 (5.7)
No. Organ Dysfunctions † <0.001
1 12,764 (45.0) 5367 (45.5) 7397 (44.7)
2 7365 (26.0) 3274 (27.8) 4091 (24.7)
>2 7095 (25.0) 2565 (21.7) 4530 (27.4)
Type of Dysfunction ‡
Respiratory 15,159 (53.4) 6560 (55.6) 8599 (51.9) <0.001
Cardiovascular 13,178 (46.5) 5671 (48.1) 7507 (45.4) <0.001
Renal 10,800 (38.1) 3713 (31.5) 7087 (42.8) <0.001
Haematological 5652 (20.0) 2383 (20.2) 3269 (19.8) 0.350
Neurological 3145 (11.1) 1358 (11.5) 1787 (10.8) 0.059
Hepatic 2491 (8.8) none 2491 (15.1) <0.001
Metabolic 2471 (8.7) 1025 (8.7) 1446 (8.7) 0.888
Invasive Therapeutic Measures
Mechanical ventilation 10,056 (35.5) 4481 (38.0) 5575 (33.7) <0.001
Haemodyalisis 3191 (11.3) 747 (6.3) 2444 (14.8) <0.001
In-Hospital Death 6808 (24.0) 1588 (13.5) 5220 (31.5) <0.001
Hospital LOS, d, mean ± SD 28.44 ± 37.70 28.06 ± 37.90 28.72 ± 37.55 0.149
Hospitalization Cost, Euros mean ± SD 17,878 ± 22,348 17,888 ± 23,486 17,871 ± 21,501 0.949
* Comorbidity is defined by the Charlson Index. Cases with a Charlson Index of 0 are considered ”without
comorbidities”. Cases with a Charlson index >0 are considered “with comorbidities”. Comparisons are made
between cases without and with comorbidities (p-Value). Values in parentheses are percentages. SD: standard
deviation. COPD: chronic obstructive pulmonary disease. LOS: length of hospital stay. ‡ Subgroups not mutually
exclusive. d: days. † Not specified No. organ dysfunctions: 1127 cases (3.98%).
Table 2. In-hospital deaths. General characteristics, case-fatality and risk (n = 6808).




OR (95% CI), p-Value
Sex
Women 2455 20.72 Referencegroup Reference group
Men 4353 26.38 1.37 (1.30, 1.45) 1.12 (1.05, 1.19)
Age-Group (years)
20–24 405 17.01 Referencegroup Reference group
25–29 611 18.99 1.14 (0.99, 1.31) 1.10 (0.94, 1.28), 0.224
30–34 1050 21.12 1.31 (1.15, 1.48) 1.19 (1.03, 1.36), 0.016
35–39 1738 23.85 1.53 (1.36, 1.72) 1.28 (1.13, 1.47), <0.001
40–44 3004 28.62 1.96 (1.74, 2.19) 1.48 (1.30, 1.68), <0.001
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OR (95% CI), p-Value
Charlson Index Comorbidity
0 1588 13.46 Referencegroup Reference group
>0 5220 31.54 2.96 (2.78, 3.15) 2.82 (2.63, 3.01), <0.001
Diagnostic Categories
Medical 4457 24.04 Referencegroup Reference group
Surgical 2338 23.91 0.99 (0.94, 1.05) Not applicable
Pathogens Identified
No 3663 30.21 Referencegroup Reference group
Yes 3145 19.38 0.56 (0.53, 0.59) 0.68 (0.64, 0.72), <0.001
Principal Site of Infection
Respiratory 2179 25.90 1.16 (1.09, 1.23) 1.15 (1.06, 1.25), 0.001
Abdominal 804 24.58 1.04 (0.95, 1.13) Not applicable
Genitourinary 555 11.21 0.35 (0.32, 0.38) 0.53 (0.48, 0.60), <0.001
Soft tissue 223 17.63 0.67 (0.58, 0.77) 0.80 (0.67, 0.94), 0.007
Procedure-related 755 17.35 0.62 (0.57, 0.68) 0.80 (0.73, 0.89), <0.001
Not specified 2483 34.91 2.10 (1.98, 2.23) 1.69 (1.55, 1.84), <0.001
No. Organ Dysfunctions
1 1634 12.80 Referencegroup Reference group
2 1850 25.12 2.28 (2.12, 2.46) 2.27 (2.10, 2.45), <0.001
>2 3171 44.69 5.50 (5.13, 5.90) 5.06 (4.70, 5.45), <0.001
OR, odds ratio; 95% CI, 95% confidence interval.
The multivariate logistic regression analysis revealed that a greater age, the failure to detect
the source of infection, the non-identification of the responsible microorganism, the extent of organ
dysfunction and the presence of comorbidities were significantly associated with an increased risk
of mortality (Table 2). When we perform the same analysis stratified by the presence or absence of
comorbidities, as indicated by Charlson’s index, it is observed that, except for sex, mortality risk factors
are the same with small differences in the odds ratios ORs (Table 3).
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Table 3. In-hospital mortality according to the presence or absence of comorbidities.
Characteristic Multivariate OR (95%CI), p-Value
Without Comorbidities With Comorbidities
Sex
Women Reference group Reference group
Men 1.27 (1.13, 1.43), <0.001 1.06 (0.98, 1.14), 0.146
Age-group (yrs)
20–24 Reference group Reference group
25–29 1.09 (0.85, 1.39), 0.508 1.11 (0.92, 1.35), 0.274
30–34 1.20 (0.95, 1.51), 0.118 1.19 (0.99, 1.41), 0.059
35–39 1.14 (0.92, 1.42), 0.228 1.35 (1.14, 1.60), <0.001
40–44 1.44 (1.16, 1.77), 0.001 1.51 (1.28, 1.77), <0.001
Pathogens identified
No Reference group Reference group
Yes 0.79 (0.71, 0.89), <0.001 0.63 (0.59, 0.68), <0.001
Principal site of infection
Respiratory 1.17 (1.01, 1.36), 0.044 1.14 (1.04, 1.25), 0.007
Abdominal Not applicable Not applicable
Genitourinary 0.55 (0.45, 0.68), <0.001 0.53 (0.47, 0.60), <0.001
Soft tissue 0.70 (0.51, 0.97), 0.030 0.82 (0.68, 0.99), 0.047
Procedure-related 1.01 (0.85, 1.21), 0.895 0.72 (0.64, 0.81), <0.001
Others/Not specified 1.75 (1.47, 2.06), <0.001 1.67 (1.51, 1.84), <0.001
No. organ dysfunctions
1 Reference group Reference group
2 2.54 (2.19, 2.95), <0.001 2.17 (1.98, 2.37), <0.001
>2 5.51 (4.78, 6.36), <0.001 4.88 (4.48, 5.32), <0.001
OR, odds ratio; 95% CI, 95% confidence interval.
3.1. Trends
3.1.1. Incidence
Regarding the whole population analyzed, and as shown in Table 4, the incidence of sepsis has
discretely increased over the six years of the study, though not significantly. When adjusted by sex,
there was no significant change in men, however, a significant increase was detected in the incidence
rate in women.
Rates also increased significantly in cases with a Charlson’s index of zero but not in those with
comorbidities. Additionally, our data show a decreasing rate over time of cases with one or two
organ dysfunctions.
3.1.2. In-Hospital Mortality
The temporal analysis indicated a significant drop in case-fatality rate CFR both overall and in
each of the subsets examined (Table 4), however, the decrease produced was variable and lower in
men than women. Similarly, Table 4 reveals that the fall was significant both in cases with a Charlson’s
index of zero, as in those with comorbidities, although it was greater in the former. When we assessed
the changes produced in CFR by number of organ dysfunctions, this variable was observed to fall in
all cases, although the decrease was lower in the case of the dysfunction of more than two organs.
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Table 4. Incidence and mortality trends of sepsis in adults aged 20–44 years.
Variable 2006 2015 Change WholePeriod (%)
Annual Average Percent
Change (%, 95% CI)
Rates
Adjusted incidence ‡
Overall 13.5 17.1 26.7 1.5 (0, 3.0)
Women 10.3 15.9 54.4 3.8 (2.1, 5.5) †
Men 16.5 18.2 10.3 −0.2 (−1.6, 1.4)
Charlson Index (%)
0 38.6 44.6 15.5 1.3 (0.6, 1.9) †
>0 61.4 55.4 −9.8 −0.9 (−1.3, −0.4) †
No. organ dysfunctions
(%)
1 48.0 45.0 −6.2 −0.6 (−1.4, 0.2)
2 28.9 23.9 −17.3 −1.6 (−2.4, −0.9) †
>2 21.7 24.9 14.7 0.6 (−0.8, 2.1)
CRF (%)
Overall 31.1 18.6 −40.2 −5.9 (−6.6, −5.2) †
Sex
Women 27.9 14.6 −47.7 −6.6 (−7.8, −5.4) †
Men 33.0 21.9 −33.6 −5.1 (−6.1, −4.2) †
Charlson’s index
0 19.0 9.9 −47.9 −8.1 (−10.1, −6.1) †
>0 38.7 25.6 −33.8 −4.7 (−5.2, −4.2) †
No. organ dysfunctions
1 18.6 11.0 −40.9 −6.6 (−8.7, −4.4) †
2 33.9 17.7 −47.8 −7.0 (−8.2, −5.8) †
>2 55.1 35.7 −35.2 −4.6 (−5.4, −3.9) †
† The Annual percent change is significantly different from zero (Poisson regression, p < 0.05). ‡ per 100,000 persons.
4. Discussion
This is the first study to provide representative national estimates of epidemiological characteristics
and incidence and mortality trends of sepsis in young Spanish adults, to our knowledge. Our findings
reveal that sepsis is a common and frequently fatal condition among adults aged 20–44 years. Trends
indicate that incidence rates are increasing in women but not in men, whereas in-hospital mortality is
decreasing. Additionally, sepsis associates with a substantial use of hospital resources.
The incidence of sepsis observed was 16.4 cases per 100,000 persons aged 20–44 years. Our data
confirmed that, even in this young age group, its frequency was defined by patient age [19] and was
very much higher in individuals aged 40–44 years than in those aged between 20 and 24 years. Sepsis
also more frequently affects men than women [4,7], something that literature has linked to a distinct
immune response between men and women, suggesting an advantageous response from women to
an infection [19]. However, in contrast with the findings of others who report an overall increase
in incidence rates of sepsis in the general population [4,7,8], in our study only women showed a
significant increase over the 10-year study period. Regrettably, the characteristics of our dataset do
not permit us to identify the causes of this particular increase in women, nor if it may be related to
differences in individual risk patterns or care-level determinants, but we feel that this finding merits
further inquiry.
Among the most relevant findings of our study was the high in-hospital mortality associated
with sepsis in the young adult, which amounted to 24% of all episodes. Mortality was higher in
men than women and also shows a clear association with age and, especially, with the presence of
comorbidities and the number of organ dysfunctions. Accordingly, age acts as an independent risk
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factor of mortality [20] even in the young adult and, as our data show, its impact is aggravated by the
presence of comorbidities.
Though the capacity of comorbidities to affect the risk of sepsis remains unclear [21], our
observation that around 60% of the cases in our cohort showed comorbidities with the predominance
of liver disease, cancer and AIDS, confirms the results of others who suggest that chronic diseases,
specifically those mentioned here, increase this risk [13,20,21]. Besides a high proportion of men and a
difference in age, which was greater among cases with comorbidities, the most appreciable differences
between those with and without comorbidities was a greater extent of organ dysfunction along with a
greater frequency of renal dysfunction and a higher mortality in the former. This corroborates the fact
that the presence of comorbidities promotes the development of multiple organ dysfunction [22] and
has a great influence on the outcome of patients with sepsis [13,23]. Found in our study, this factor
increased the risk of death by 2.82-fold.
We should highlight, however, the elevated in-hospital mortality observed for cases without
comorbidities. This was 13.5% and much higher than that associated with other diseases in the 20–44
years age group in our country [9]. Further, we must also highlight that the proportion of cases without
comorbidities has increased over time. Although we cannot establish a formal cause for this rise, it
may be related to the increasing incidence in women who constitute a group with less comorbidity
burden as measured by the Charlson Index.
Additionally, it was especially noticeable that both in cases with or without comorbidities, the
presence of two or more organ dysfunctions was a critical event with a cumulative impact on the risk
of death in the septic young adult [24].
The mortality observed here doubles the 12% described by Kaukonen [25], who analyzed the
data of 15,471 cases of severe sepsis in patients aged ≤44 years in a retrospective observational study
performed in the intensive care units (ICUs) of Australia and New Zealand between 2000 and 2012.
This discrepancy could be explained in part by differences in information systems, methodology and
setting. Although Kaukonen analyzed cases from ICUs and we looked at a national-level population,
notable clinico-demographic differences were observed with a profile that suggests greater severity and
mortality risk in our study, as our cases were older and showed greater pulmonary, cardiovascular and
renal organ dysfunction and a greater comorbidity burden. Regarding this last issue, in the absence
of comorbidities, the mortality observed in the present study is greater than the 8% described by
Kaukonen, although the systems used to assess comorbidities differed between the two studies.
Both studies coincided, however, in observing a significant decline in hospital mortality rates of
sepsis in patients aged ≤44 years. Considering our study, we observed from 2006 to 2015 an annual
reduction in hospital mortality of 5.9%, a similar figure to that noted by Kaukonen. This decrease in
mortality was observed both in men and women but was less marked in cases with comorbidities and
in those showing two or more organ dysfunctions.
Concerning resource utilization, both mean hospital stay and costs were elevated and much above
the mean figures provided by the National Health Service for all-cause hospitalizations in this age
group. Over the period analysed, these figures were 4.9 days of mean stay and 3219.26 Euros per
hospitalization [9]. We could easily speculate that this can be related to the use of costly invasive
therapeutic interventions in sepsis [26,27].
While sepsis is often associated with elderly subjects, this study indicates that it is frequent and
related to a high in-hospital mortality in young adults. According to data from the UN, adults aged
20–44 years in 2015 accounted for 33.7% of the Spanish population [8]. This means sepsis in this
age group is a real challenge for clinicians and healthcare systems. Our findings identify a need to
implement measures designed to optimize its prevention and management, including early diagnostic
and therapeutic measures, especially in high-risk patients with comorbidities, targeted at reducing
the development and progression of organ dysfunction and, consequently, mortality. Essentially, as
comorbidities are usually easily recognizable chronic conditions, if these are managed early on and
adequately, it could be possible to improve outcomes in these patients [28].
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Clinical-administrative databases are an essential tool for health research [16,29]. Spain has a
large population database which is required by law and is widely representative as it covers practically
all hospitalizations produced annually, allowing for accurate epidemiological estimates. During this
study, we followed RECORD guidelines for observational studies’ routinely-collected health data [30].
Notwithstanding, due to its inherent characteristics, the database employed has some limitations.
Although national guidelines exist for the use of the coding system, this may not be uniform across
the national healthcare system and we cannot rule out coding errors, despite regular audits; however,
we consider systematic coding errors highly unlikely. Moreover, due to its confidential nature, the
database used lacks complete clinical information, precluding any causal inferences. The use of national
databases is, nevertheless, well established for the epidemiological monitoring of the incidence and
mortality of sepsis [31,32]. Additionally, the results of a recent meta-analysis confirm the essential role
of administrative data for surveillance of mortality trends in sepsis [33]. Another limitation is that
studies based on hospital discharge data do not include non-hospitalized cases of sepsis such that
our estimates of incidence and mortality are conservative. Similarly, deaths produced after hospital
discharge also will be missed [5,34].
5. Conclusions
This population-based nationwide study shows that sepsis is a common, and frequently fatal,
condition among adults aged 20–44 years. Data over time indicate that incidence rates are increasing in
women but not in men and in cases without comorbidity, findings that need further research. Conversely,
in-hospital mortality shows a decreasing trend. This trend was lower in cases with comorbidity and
dysfunction of more than two organs. Additionally, sepsis associates with a substantial use of
hospital resources.
Author Contributions: Conceptualization, C.B.; methodology, C.B. and T.L.-C.; software, T.L.-C.; validation, C.B.
and T.L.-C.; formal analysis, T.L.-C.; investigation, C.B.; resources, C.B.; data curation, T.L.-C.; writing—original
draft preparation, C.B.; writing—review and editing, C.B.; visualization, T.L.-C.; funding acquisition, C.B. All
authors have read and agreed to the published version of the manuscript.
Funding: This research was supported by the Carlos III Health Institute (grant number PI14/00081).
Acknowledgments: We would like to thank the Sub-Directorate General for Healthcare Information and Innovation
of the Spanish Ministry of Health, Consumer Affairs and Social Welfare for providing the data used in this study.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to
publish the results.
References
1. Singer, M.; Deutschman, C.S.; Seymour, C.W.; Shankar-Hari, M.; Annane, D.; Bauer, M. The Third International
Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016, 315, 801. [CrossRef] [PubMed]
2. Reinhart, K.; Daniels, R.; Kissoon, N.; Machado, F.R.; Schachter, R.D.; Finfer, S. Recognizing Sepsis as a
Global Health Priority—A WHO Resolution. N. Engl. J. Med. 2017, 377, 414–417. [CrossRef] [PubMed]
3. Angus, D.C. The lingering consequences of sepsis: A hidden public health disaster? JAMA 2010, 304,
1833–1834. [CrossRef] [PubMed]
4. Angus, D.C.; Linde-Zwirble, W.T.; Lidicker, J.; Clermont, G.; Carcillo, J.; Pinsky, M.R. Epidemiology of severe
sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med.
2001, 29, 1303–1310. [CrossRef]
5. Winters, B.D.; Eberlein, M.; Leung, J.; Needham, D.M.; Pronovost, P.J.; Sevransky, J.E. Long-term mortality
and quality of life in sepsis: A systematic review. Crit. Care Med. 2010, 38, 1276–1283. [CrossRef]
6. United Nations, Department of Economic and Social Affairs, Population Division (2017). World Population
Prospects: The 2017 Revision, Custom Data Acquired via Website. Available online: https://esa.un.org/unpd/
wpp/DataQuery/ (accessed on 5 March 2019).
7. Martin, G.S.; Mannino, D.M.; Eaton, S.; Moss, M. The epidemiology of sepsis in the United States from 1979
through 2000. N. Engl. J. Med. 2003, 348, 1546–1554. [CrossRef]
J. Clin. Med. 2020, 9, 77 12 of 13
8. Dombrovskiy, V.Y.; Martin, A.A.; Sunderram, J.; Paz, H.L. Rapid increase in hospitalization and mortality
rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit. Care Med. 2007, 35,
1244–1250. [CrossRef]
9. Ministry of Health, Consumer Affairs and Social Welfare. Healthcare Services Activity and Quality.
Annual Report of the National Health Service. Available online: https://www.mscbs.gob.es/estadEstudios/
estadisticas/sisInfSanSNS/tablasEstadisticas/InfAnualSNS2017/5_CAP_17.pdf (accessed on 8 April 2019).
10. Lagu, T.; Rothberg, M.B.; Shieh, M.S.; Pekow, P.S.; Steingrub, J.S.; Lindenauer, P.K. What is the best method
for estimating the burden of severe sepsis in the United States? J. Crit. Care 2012, 27, 414-e1. [CrossRef]
11. Deyo, R.A.; Cherkin, D.C.; Ciol, M.A. Adapting a clinical comorbidity index for use with ICD-9-CM
administrative databases. J. Clin. Epidemiol. 1992, 45, 613–619. [CrossRef]
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